Braskem Loses US$189M as Debt Talks Drag On

Braskem, the largest resin producer in the Americas, reported a net loss of R$1.07 billion (US$189 million) in Q3 2026, reversing a profit from the previous quarter. The loss was driven by lower gross profit due to narrowed chemical and petrochemical spreads. The company's recurring EBITDA fell 63% to R$1.96 billion (US$347 million), while net revenue increased 13% year-over-year to R$19.58 billion (US$3.46 billion).

Original reporting
Published Nov 13, 2026, 1:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 2:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Braskem Loses US$189M as Debt Talks Drag On — source image
Decision brief

The 30-second read

$BAKBearishMed
01

Why it matters

The earnings miss and debt concerns could trigger a sell‑off of the BAK ADR, while the restructuring outcome remains uncertain.

02

Market read

First‑report earnings loss and debt restructuring details provide fresh material for traders holding or shorting BAK.

03

What to watch

Potential upside from higher resin export volumes and any favorable credit terms in the restructuring plan.

Relevance 7/10Novelty 7/10Timing: post‑earnings reaction

Background

Braskem, the largest resin producer in the Americas, filed an out‑of‑court restructuring plan and missed a scheduled debt payment.

Company-level read

Ticker impact

$BAKBearishHigh confidence
Context

Braskem posted a Q3 2026 net loss of US$189M and disclosed a worsening debt restructuring outlook.

Expected impact

downward pressure as investors price higher leverage and missed profit.

Evidence & confidence

Loss reversal, 63% EBITDA decline, and missed debt payment signal financial stress.

Market effects

Highlights weakness in the Latin American chemicals sector and may pressure peers with similar exposure.

Brazilian market could see broader sentiment drag on industrial stocks.

Limited to investors holding the ADR; no immediate global macro effect.

Counterpoint

If the restructuring succeeds, the stock may be undervalued after the sharp sell‑off.

Key entities

  • Braskem S.A.

    Brazilian chemicals group reporting Q3 loss and debt restructuring.

  • Deloitte

    Auditor of Braskem's quarterly accounts.

Related articles

$BAKMed

Braskem Loss Hits US$189M as Creditors Wait

Braskem, a Brazilian resin producer, reported a R$1.07 billion (US$189 million) loss in Q3 2026, citing narrower spreads and high financing costs. Net revenue rose 13% to R$19.58 billion (US$3.46 billion). Creditors have not agreed to a debt deal, and auditor Deloitte noted material uncertainty about the company's ability to continue as a going concern.

$BAKMed

Braskem Q3 Earnings Call Highlights

Braskem (NYSE:BAK) is pursuing a capital structure solution with advisers and interested parties, according to CFO Carlos Brandão. The company is focused on reaching agreement on essential commercial terms. Braskem expects modest recovery in Q4 spreads, with increases forecasted for Brazil's polyethylene, polypropylene, and Mexico's polyethylene-ethane spreads. The company reported a BRL 3.2 billion provision balance for a geological event in Alagoas, with 99.9% of relocation completed.

$BAKHigh

BRASKEM SA (BAK): Financial results for Q3 2026

BRASKEM SA (BAK) furnished an SEC Form 6-K — earnings release. CONTENTS 1. OPERATIONAL AND FINANCIAL INDICATORS 6 2. EXECUTIVE SUMMARY 3Q26 7 3. PERFORMANCE BY SEGMENT 3Q26 8 3.1 BRAZIL/SOUTH AMERICA 8 3.1.2 OVERVIEW 9 3.2 RENEWABLES OVERVIEW 13 3.3 UNITED STATES AND EUROPE 14 3.4 MEXICO 16 4. CONSOLIDATED FINANCIAL OVERVIEW 18 4.1 CONSOLIDA